Clinical Trials List
2020-05-20 - 2023-09-11
Phase III
Suspended4
ICD-10L20.0
Besnier's prurigo
ICD-10L20.81
Atopic neurodermatitis
ICD-10L20.82
Flexural eczema
ICD-10L20.83
Infantile (acute) (chronic) eczema
ICD-10L20.84
Intrinsic (allergic) eczema
ICD-10L20.89
Other atopic dermatitis
ICD-10L20.9
Atopic dermatitis, unspecified
ICD-9691.8
Other atopic dermatitis and related conditions
-
Trial Applicant
AbbVie
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 張廖年峰 Division of Dermatology
The Actual Total Number of Participants Enrolled
0 Suspended
Co-Principal Investigator
- 洪琡茹 Division of Dermatology
The Actual Total Number of Participants Enrolled
0 Suspended
Co-Principal Investigator
- 卓雍哲 Division of Dermatology
- WEI-HSIN WU Division of Dermatology
- Chih-Chieh Chan Division of Dermatology
The Actual Total Number of Participants Enrolled
0 Suspended
Co-Principal Investigator
- Yu-Chen Huang Division of Dermatology
The Actual Total Number of Participants Enrolled
0 Suspended
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
8 participants
-
Global
600 participants
